Nanoparticulation of Prodrug into Medicines for Cancer Therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Nanoparticulation of Prodrug into Medicines for Cancer Therapy ; day:29 ; month:07 ; year:2021 ; extent:34
Advanced science ; (29.07.2021) (gesamt 34)

Creator: Zhang, Yuezhou
Cui, Huaguang
Zhang, Ruiqi
Zhang, Hongbo
Huang, Wei

DOI: 10.1002/advs.202101454

URN: urn:nbn:de:101:1-2021072915231499100844

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhang, Yuezhou
Cui, Huaguang
Zhang, Ruiqi
Zhang, Hongbo
Huang, Wei

Other Objects (12)

Enzyme Prodrug Therapy Engineered into Electrospun Fibers with Embedded Liposomes for Controlled, Localized Synthesis of Therapeutics

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

The challenge of developing human 3D organoids into medicines

Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?

Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy

Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy

Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy

Dual-vector prodrug activator gene therapy using retroviral replicating vectors

Near-infrared light-triggered nano-prodrug for cancer gas therapy

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy

Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy

Enzyme Prodrug Therapy Engineered into Electrospun Fibers with Embedded Liposomes for Controlled, Localized Synthesis of Therapeutics

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

The challenge of developing human 3D organoids into medicines

Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?

Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy

Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy

Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy

Dual-vector prodrug activator gene therapy using retroviral replicating vectors

Near-infrared light-triggered nano-prodrug for cancer gas therapy

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy

Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy

Enzyme Prodrug Therapy Engineered into Electrospun Fibers with Embedded Liposomes for Controlled, Localized Synthesis of Therapeutics

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

The challenge of developing human 3D organoids into medicines

Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?

Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy

Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy

Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy

Dual-vector prodrug activator gene therapy using retroviral replicating vectors

Near-infrared light-triggered nano-prodrug for cancer gas therapy

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy

Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Nanoparticulation of Prodrug into Medicines for Cancer Therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Enzyme Prodrug Therapy Engineered into Electrospun Fibers with Embedded Liposomes for Controlled, Localized Synthesis of Therapeutics

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

The challenge of developing human 3D organoids into medicines

Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?

Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy

Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy

Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy

Dual-vector prodrug activator gene therapy using retroviral replicating vectors

Near-infrared light-triggered nano-prodrug for cancer gas therapy

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy

Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy

Enzyme Prodrug Therapy Engineered into Electrospun Fibers with Embedded Liposomes for Controlled, Localized Synthesis of Therapeutics

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

The challenge of developing human 3D organoids into medicines

Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?

Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy

Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy

Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy

Dual-vector prodrug activator gene therapy using retroviral replicating vectors

Near-infrared light-triggered nano-prodrug for cancer gas therapy

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy

Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy

Enzyme Prodrug Therapy Engineered into Electrospun Fibers with Embedded Liposomes for Controlled, Localized Synthesis of Therapeutics

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

The challenge of developing human 3D organoids into medicines

Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?

Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy

Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy

Rational Design of Responsive Prodrug-based Nanomedicines for Antitumor Therapy

Dual-vector prodrug activator gene therapy using retroviral replicating vectors

Near-infrared light-triggered nano-prodrug for cancer gas therapy

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy

Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy

Related objects

Reset password